Jeremy Grenier

1.1k total citations
18 papers, 876 citations indexed

About

Jeremy Grenier is a scholar working on Immunology, Molecular Biology and Neurology. According to data from OpenAlex, Jeremy Grenier has authored 18 papers receiving a total of 876 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Immunology, 7 papers in Molecular Biology and 7 papers in Neurology. Recurrent topics in Jeremy Grenier's work include Neuroinflammation and Neurodegeneration Mechanisms (7 papers), Immunotherapy and Immune Responses (5 papers) and Virus-based gene therapy research (4 papers). Jeremy Grenier is often cited by papers focused on Neuroinflammation and Neurodegeneration Mechanisms (7 papers), Immunotherapy and Immune Responses (5 papers) and Virus-based gene therapy research (4 papers). Jeremy Grenier collaborates with scholars based in United States, Canada and Germany. Jeremy Grenier's co-authors include Evan R. Jellison, Rodney M. Ritzel, Louise D. McCullough, Rajkumar Verma, Joshua Crapser, Anita Patel, Kamal M. Khanna, Stephen T. Yeung, Kyle Denton and Ling Lei and has published in prestigious journals such as The Journal of Immunology, Stroke and International Journal of Cancer.

In The Last Decade

Jeremy Grenier

18 papers receiving 867 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jeremy Grenier United States 10 448 329 268 141 126 18 876
Hannah Van Hove Belgium 7 687 1.5× 506 1.5× 238 0.9× 49 0.3× 50 0.4× 10 1.0k
Robyn Oldfield New Zealand 11 473 1.1× 193 0.6× 173 0.6× 41 0.3× 43 0.3× 15 763
Mariola Matysiak Poland 15 166 0.4× 222 0.7× 265 1.0× 50 0.4× 68 0.5× 34 825
Trina Johnson Canada 16 452 1.0× 544 1.7× 439 1.6× 48 0.3× 83 0.7× 19 1.2k
Nathalie Koning Netherlands 12 504 1.1× 517 1.6× 225 0.8× 50 0.4× 95 0.8× 13 1.0k
Amber L. Rowse United States 12 288 0.6× 265 0.8× 287 1.1× 42 0.3× 129 1.0× 13 847
Hanane Touil Canada 11 446 1.0× 570 1.7× 204 0.8× 38 0.3× 113 0.9× 18 1.1k
Vladislav Tsiperson United States 10 251 0.6× 247 0.8× 220 0.8× 58 0.4× 66 0.5× 12 767
Marloes van Zwam Netherlands 10 295 0.7× 333 1.0× 190 0.7× 31 0.2× 109 0.9× 11 743
Jennifer V. Welser-Alves United States 14 347 0.8× 91 0.3× 252 0.9× 56 0.4× 48 0.4× 17 693

Countries citing papers authored by Jeremy Grenier

Since Specialization
Citations

This map shows the geographic impact of Jeremy Grenier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jeremy Grenier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jeremy Grenier more than expected).

Fields of papers citing papers by Jeremy Grenier

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jeremy Grenier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jeremy Grenier. The network helps show where Jeremy Grenier may publish in the future.

Co-authorship network of co-authors of Jeremy Grenier

This figure shows the co-authorship network connecting the top 25 collaborators of Jeremy Grenier. A scholar is included among the top collaborators of Jeremy Grenier based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jeremy Grenier. Jeremy Grenier is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Mueller, Katherine P., Jeremy Grenier, & Evan W. Weber. (2025). CAR T cell persistence in cancer. Trends in cancer. 11(10). 1005–1018. 1 indexed citations
2.
Grenier, Jeremy, Alexandra J. Borst, Sarah E. Sheppard, et al.. (2023). Pathogenic variants inPIK3CAare associated with clinical phenotypes of kaposiform lymphangiomatosis, generalized lymphatic anomaly, and central conducting lymphatic anomaly. Pediatric Blood & Cancer. 70(9). e30419–e30419. 9 indexed citations
3.
Grenier, Jeremy, Stephen T. Yeung, & Kamal M. Khanna. (2018). Combination Immunotherapy: Taking Cancer Vaccines to the Next Level. Frontiers in Immunology. 9. 610–610. 51 indexed citations
4.
Ritzel, Rodney M., Yun‐Ju Lai, Joshua Crapser, et al.. (2018). Aging alters the immunological response to ischemic stroke. Acta Neuropathologica. 136(1). 89–110. 146 indexed citations
5.
Grenier, Jeremy, Stephen T. Yeung, Zhijuan Qiu, Evan R. Jellison, & Kamal M. Khanna. (2018). Combining Adoptive Cell Therapy with Cytomegalovirus-Based Vaccine Is Protective against Solid Skin Tumors. Frontiers in Immunology. 8. 1993–1993. 22 indexed citations
6.
Grenier, Jeremy, Zhijuan Qiu, & Kamal M. Khanna. (2016). Adoptive cell transfer enhances antitumor response generated by Cytomegalovirus-based vaccine. The Journal of Immunology. 196(1_Supplement). 143.20–143.20. 1 indexed citations
7.
Ritzel, Rodney M., Joshua Crapser, Anita Patel, et al.. (2016). Age-Associated Resident Memory CD8 T Cells in the Central Nervous System Are Primed To Potentiate Inflammation after Ischemic Brain Injury. The Journal of Immunology. 196(8). 3318–3330. 129 indexed citations
8.
Ritzel, Rodney M., Anita Patel, Jeremy Grenier, et al.. (2015). Functional differences between microglia and monocytes after ischemic stroke. Journal of Neuroinflammation. 12(1). 106–106. 242 indexed citations
9.
Grenier, Jeremy, et al.. (2015). Abstract T P225: Loss of Pregnane X Receptor Impairs Stroke Recovery. Stroke. 46(suppl_1). 1 indexed citations
10.
Qiu, Zhijuan, Jeremy Grenier, & Kamal M. Khanna. (2015). Reviving virus based cancer vaccines by using cytomegalovirus vectors expressing modified tumor antigens. OncoImmunology. 5(1). e1056974–e1056974. 5 indexed citations
11.
Koellhoffer, Edward C., Jeremy Grenier, Rodney M. Ritzel, & Louise D. McCullough. (2015). Abstract T P80: Inhibition of Ezh2 Leads to Decreased M1 and Enhanced M2 Microglia Phenotypes. Stroke. 46(suppl_1). 2 indexed citations
12.
Koellhoffer, Edward C., et al.. (2015). Abstract W P98: Monocyte Chemotactic Protein-3 Elevated in Stoke and Aging. Stroke. 46(suppl_1). 1 indexed citations
13.
Qiu, Zhijuan, Jeremy Grenier, Oriana A. Perez, et al.. (2015). Cytomegalovirus-Based Vaccine Expressing a Modified Tumor Antigen Induces Potent Tumor-Specific CD8+ T-cell Response and Protects Mice from Melanoma. Cancer Immunology Research. 3(5). 536–546. 52 indexed citations
14.
Koellhoffer, Edward C., Rodney M. Ritzel, Jeremy Grenier, & Louise D. McCullough. (2014). Tilting the balance of M1/M2 microglial phenotypes: Inhibition of Ezh2 leads to decreased M1 and enhanced M2 phenotype. Journal of Neuroimmunology. 275(1-2). 157–157. 3 indexed citations
15.
Denton, Kyle, Ling Lei, Jeremy Grenier, et al.. (2013). Loss of Spastin Function Results in Disease-Specific Axonal Defects in Human Pluripotent Stem Cell-Based Models of Hereditary Spastic Paraplegia. Stem Cells. 32(2). 414–423. 110 indexed citations
16.
Amrein, Lilian, M. Shawi, Jeremy Grenier, Raquel Aloyz, & Lawrence Panasci. (2012). The phosphatidylinositol‐3 kinase I inhibitor BKM120 induces cell death in B‐chronic lymphocytic leukemia cells in vitro. International Journal of Cancer. 133(1). 247–252. 36 indexed citations
17.
Davidson, David, Jeremy Grenier, Verónica L. Martínez‐Marignac, et al.. (2011). Effects of the novel DNA dependent protein kinase inhibitor, IC486241, on the DNA damage response to doxorubicin and cisplatin in breast cancer cells. Investigational New Drugs. 30(4). 1736–1742. 21 indexed citations
18.
Davidson, David, Verónica L. Martínez‐Marignac, Lilian Amrein, et al.. (2011). Irinotecan and DNA-PKcs inhibitors synergize in killing of colon cancer cells. Investigational New Drugs. 30(3). 1248–1256. 44 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hannah Van Hove Breakdown of academic impact, for papers by Robyn Oldfield Breakdown of academic impact, for papers by Mariola Matysiak Breakdown of academic impact, for papers by Trina Johnson Breakdown of academic impact, for papers by Nathalie Koning Breakdown of academic impact, for papers by Amber L. Rowse Breakdown of academic impact, for papers by Hanane Touil Breakdown of academic impact, for papers by Vladislav Tsiperson Breakdown of academic impact, for papers by Marloes van Zwam Breakdown of academic impact, for papers by Jennifer V. Welser-Alves
Rankless by CCL
2026